ATE266418T1 - Malignitätsunterdrückung durch verwendung von ribonucleotid reductase r1 - Google Patents

Malignitätsunterdrückung durch verwendung von ribonucleotid reductase r1

Info

Publication number
ATE266418T1
ATE266418T1 AT98910553T AT98910553T ATE266418T1 AT E266418 T1 ATE266418 T1 AT E266418T1 AT 98910553 T AT98910553 T AT 98910553T AT 98910553 T AT98910553 T AT 98910553T AT E266418 T1 ATE266418 T1 AT E266418T1
Authority
AT
Austria
Prior art keywords
ribonucleotide reductase
mammal
cell
provides
malignance
Prior art date
Application number
AT98910553T
Other languages
English (en)
Inventor
Jim A Wright
Aiping H Young
Original Assignee
Genesense Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genesense Technologies Inc filed Critical Genesense Technologies Inc
Application granted granted Critical
Publication of ATE266418T1 publication Critical patent/ATE266418T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y117/00—Oxidoreductases acting on CH or CH2 groups (1.17)
    • C12Y117/04—Oxidoreductases acting on CH or CH2 groups (1.17) with a disulfide as acceptor (1.17.3)
    • C12Y117/04001—Ribonucleoside-diphosphate reductase (1.17.4.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98910553T 1997-03-19 1998-03-18 Malignitätsunterdrückung durch verwendung von ribonucleotid reductase r1 ATE266418T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4083797P 1997-03-19 1997-03-19
US6066997P 1997-10-02 1997-10-02
PCT/CA1998/000242 WO1998041231A1 (en) 1997-03-19 1998-03-18 Suppression of malignancy utilizing ribonucleotide reductase r1

Publications (1)

Publication Number Publication Date
ATE266418T1 true ATE266418T1 (de) 2004-05-15

Family

ID=26717500

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98910553T ATE266418T1 (de) 1997-03-19 1998-03-18 Malignitätsunterdrückung durch verwendung von ribonucleotid reductase r1

Country Status (11)

Country Link
US (2) US6472376B2 (de)
EP (1) EP0971731B1 (de)
JP (1) JP2002501486A (de)
CN (1) CN1256632A (de)
AT (1) ATE266418T1 (de)
AU (1) AU742176B2 (de)
CA (1) CA2301874C (de)
DE (1) DE69823813T2 (de)
ES (1) ES2222577T3 (de)
HK (1) HK1024640A1 (de)
WO (1) WO1998041231A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1329146A (zh) * 2000-06-21 2002-01-02 上海博德基因开发有限公司 一种新的多肽——核苷酸还原酶10.49和编码这种多肽的多核苷酸
WO2008051527A2 (en) * 2006-10-23 2008-05-02 Psivida, Inc. Sustained release of agents for localized pain management

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3082204B2 (ja) * 1988-09-01 2000-08-28 ホワイトヘッド・インスティチュート・フォー・バイオメディカル・リサーチ 両栄養性および環境栄養性宿主域を持つ組換え体レトロウイルス
US5518913A (en) * 1991-10-10 1996-05-21 National Research Council Of Canada High level recombinant protein production using conditional helper-free adenovirus vector
US5643599A (en) * 1995-06-07 1997-07-01 President And Fellows Of Harvard College Intracellular delivery of macromolecules
WO1998000532A2 (en) 1996-07-01 1998-01-08 Wright Jim A Oligonucleotides from the untranslated regions of ribonucleotide reductase and their use to modulate cell growth
ATE309345T1 (de) 1996-08-02 2005-11-15 Genesense Technologies Inc Antitumor antisense sequenzen gegen h1 und r2 verbindungen von ribonukleotide reductase
WO2000007618A2 (en) * 1998-07-31 2000-02-17 Centre De Recherche Du Centre Hospitalier De L'universite De Montreal Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof

Also Published As

Publication number Publication date
US20020004488A1 (en) 2002-01-10
EP0971731A1 (de) 2000-01-19
JP2002501486A (ja) 2002-01-15
HK1024640A1 (en) 2000-10-20
DE69823813T2 (de) 2005-06-30
CN1256632A (zh) 2000-06-14
CA2301874C (en) 2009-02-17
AU742176B2 (en) 2001-12-20
EP0971731B1 (de) 2004-05-12
US6472376B2 (en) 2002-10-29
WO1998041231A1 (en) 1998-09-24
AU6492298A (en) 1998-10-12
US20030087866A1 (en) 2003-05-08
DE69823813D1 (de) 2004-06-17
ES2222577T3 (es) 2005-02-01
CA2301874A1 (en) 1998-09-24

Similar Documents

Publication Publication Date Title
DE69637147D1 (de) Transportproteine und deren verwendungen
DE59711812D1 (de) Rekombinante collagenase typ i aus clostridium histolyticum und ihre verwendung zur isolierung von zellen und zellverbänden
DE69937347D1 (de) Regulierung der hämatopoietischen stammzelldifferenzierung durch verwendung von menschlichen mesenchymalen stammzellen
DE69535147D1 (de) Überexpression von säugetier- und virusproteinen
DE69836092D1 (de) Rekombinatorisches klonieren unter verwendung von nukleinsaüren mit rekombinationsstellen
CA2323086A1 (en) Regulation of endogenous gene expression in cells using zinc finger proteins
ATE305972T1 (de) Herstellungsmethode von glycerin mittels rekombinanten organismen
CA2285667A1 (en) Viral vectors having chimeric envelope proteins containing the igg-binding domain of protein a
DE69834565D1 (de) Schnell erzeugung von stabilen säugertier-zellinien mit gewinnung eines hohen gehalts von recombinanten proteine
WO1999025878A3 (en) Methods for modulating and identifying cellular senescence
ATE294856T1 (de) Lunasin peptide
DE69631972D1 (de) Proliferationsinhibitor von endothellzellen und dessen verwendung
CA2260365A1 (en) Differentiation-suppressive polypeptide
WO1997039721A3 (en) Methods and compositions for regulating t cell subsets by modulating transcription factor activity
EP1702071A4 (de) Transaktivierungssystem für säugerzellen
TR200000288T2 (tr) İnsülin C-peptidin rekombinan ekspresyonu.
DE69634563D1 (de) Verbesserte verfahren zur transfektion der t-zellen
ATE266418T1 (de) Malignitätsunterdrückung durch verwendung von ribonucleotid reductase r1
ATE380873T1 (de) Prenylcystein carboxyl methyl-transferase, dns, welche für selbige kodiert, und ein verfahren zur suche nach hemmstoffen
PE42695A1 (es) Procedimiento para producir proteina c
DE59508100D1 (de) Verwendung von zelladhäsions-peptiden zur modifikation des haftungsvermögens eukaryontischer zellen untereinander
DE69332373T2 (de) Menschlicher epidermaler Gen-Promotor
ATE302282T1 (de) Erhöhte herstellung von sekretierten proteinen durch rekombinante hefezellen
RU94045945A (ru) Способ повышения экспрессии рекомбинантных белков, применение фракции яичного желтка
ATE288476T1 (de) Herstellung von proteinen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties